• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An update on intraductal and intralobular proliferative lesions of the breast.

作者信息

Abreu Rodrigo Fonseca, Gobbi Helenice, Brot Marina De

机构信息

A.C.Camargo Cancer Center, Department of Anatomic Pathology - São Paulo (SP), Brazil.

Sociedade Brasileira de Patologia - São Paulo (SP), Brazil.

出版信息

Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S121. doi: 10.1590/1806-9282.2023S121. eCollection 2023.

DOI:10.1590/1806-9282.2023S121
PMID:37556640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10411714/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a8/10411714/c248e4a24b5c/1806-9282-ramb-69-suppl1-e2023S121-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a8/10411714/c248e4a24b5c/1806-9282-ramb-69-suppl1-e2023S121-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a8/10411714/c248e4a24b5c/1806-9282-ramb-69-suppl1-e2023S121-gf01.jpg

相似文献

1
An update on intraductal and intralobular proliferative lesions of the breast.乳腺导管内及小叶内增生性病变的最新进展
Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S121. doi: 10.1590/1806-9282.2023S121. eCollection 2023.
2
Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.乳腺导管内增生：非典型导管内增生及导管原位癌组织学标准综述，包括大汗腺及乳头状病变
Ann Diagn Pathol. 1998 Apr;2(2):135-45. doi: 10.1016/s1092-9134(98)80051-8.
3
Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.雌激素受体α在乳腺导管内增生性病变中的表达模式及甲基化
Oncol Rep. 2016 Oct;36(4):1868-74. doi: 10.3892/or.2016.4988. Epub 2016 Aug 1.
4
Atypical ductal hyperplasia presenting as pseudomicrocalcifications.表现为假性微钙化的非典型导管增生。
Breast J. 2003 Jan-Feb;9(1):39-40. doi: 10.1046/j.1524-4741.2003.09113.x.
5
Acidophilic nuclear inclusions are specific for florid ductal hyperplasia among proliferative breast lesions.嗜酸性核内包涵体是增生性乳腺病变中富于细胞性导管增生的特征性表现。
Arch Pathol Lab Med. 2011 Jun;135(6):766-9. doi: 10.5858/2010-0377-OA.1.
6
[Significance of proliferative breast lesions around breast cancers].[乳腺癌周围增殖性乳腺病变的意义]
Gan To Kagaku Ryoho. 1995 Apr;22 Suppl 1:42-5.
7
"Borderline" epithelial lesions of the breast: what have we learned in the past three decades?乳腺“交界性”上皮性病变：过去三十年我们学到了什么？
Pathologica. 2021 Oct;113(5):354-359. doi: 10.32074/1591-951X-374.
8
Pattern of distribution of intraductal and infiltrating ductal carcinoma: a three-dimensional study using serial coronal giant sections of the breast.导管内癌和浸润性导管癌的分布模式：一项使用乳腺连续冠状大切片的三维研究。
Hum Pathol. 2000 Apr;31(4):464-74. doi: 10.1053/hp.2000.6536.
9
Computational pathology to discriminate benign from malignant intraductal proliferations of the breast.利用计算病理学鉴别乳腺导管内良性与恶性增殖病变。
PLoS One. 2014 Dec 9;9(12):e114885. doi: 10.1371/journal.pone.0114885. eCollection 2014.
10
Cytomorphometric differentiation of intraductal proliferative breast lesions.导管内增生性乳腺病变的细胞形态计量学鉴别
Breast Cancer. 2000 Jan;7(1):43-7. doi: 10.1007/BF02967187.

本文引用的文献

1
Learning to distinguish progressive and non-progressive ductal carcinoma in situ.学会区分进展性和非进展性导管原位癌。
Nat Rev Cancer. 2022 Dec;22(12):663-678. doi: 10.1038/s41568-022-00512-y. Epub 2022 Oct 19.
2
High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision.在核心针活检中诊断出的高风险和选择的良性乳腺病变：立即手术切除的证据和反对意见。
Mod Pathol. 2022 Nov;35(11):1500-1508. doi: 10.1038/s41379-022-01092-w. Epub 2022 Jun 2.
3
Atypical Ductal Hyperplasia-Ductal Carcinoma In Situ Spectrum: Diagnostic Considerations and Treatment Impact in the Era of Deescalation.
非典型导管增生-导管原位癌谱：降级时代的诊断考虑和治疗影响。
Surg Pathol Clin. 2022 Mar;15(1):95-103. doi: 10.1016/j.path.2021.11.006. Epub 2022 Jan 31.
4
Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.同步导管原位癌和浸润性乳腺癌中具有可比性的癌症相关突变特征。
Cancer Rep (Hoboken). 2020 Jun;3(3):e1248. doi: 10.1002/cnr2.1248. Epub 2020 May 28.
5
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma to Invasive Ductal Carcinoma.非低级别导管癌进展为浸润性导管癌的全外显子组测序分析。
Clin Cancer Res. 2020 Jul 15;26(14):3682-3693. doi: 10.1158/1078-0432.CCR-19-2563. Epub 2020 Mar 27.
6
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.多形性和显著小叶原位癌的基因组分析揭示了高度复发的 ERBB2 和 ERRB3 改变。
Mod Pathol. 2020 Jul;33(7):1287-1297. doi: 10.1038/s41379-020-0459-6. Epub 2020 Jan 13.
7
PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.PIK3CA 突变在导管原位癌和相邻浸润性乳腺癌中的作用。
Endocr Relat Cancer. 2019 May;26(5):471-482. doi: 10.1530/ERC-19-0019.
8
Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center.乳腺多形性和华丽型小叶原位癌变异型：来自单一学术中心的 85 例伴有和不伴有浸润性癌的临床病理研究。
Am J Surg Pathol. 2019 Mar;43(3):399-408. doi: 10.1097/PAS.0000000000001191.
9
Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.评估核心活检诊断为非典型性 lobular carcinoma in situ 后升级为浸润性乳腺癌和/或导管原位癌的发生率。
Ann Surg Oncol. 2019 Jan;26(1):55-61. doi: 10.1245/s10434-018-6937-0. Epub 2018 Oct 25.
10
Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.乳腺原位多形性小叶癌：单机构临床随访及集中病理检查经验
Breast Cancer Res Treat. 2017 Sep;165(2):411-420. doi: 10.1007/s10549-017-4334-1. Epub 2017 Jun 13.